Macrocyclic compounds as HCV NS3 protease inhibitors

Details for Australian Patent Application No. 2008217187 (hide)

Owner Novartis AG

Inventors Cottens, Sylvain; Brandl, Trixi; Raman, Prakash; Ehrhardt, Claus; Randl, Stefan Andreas; Parker, David Thomas; Schiering, Nikolaus; Yifru, Aregahegn; Radetich, Branko; Zheng, Rui; Fu, Jiping; Patane, Michael A.; Britt, Shawn D.; Simic, Oliver; Rigollier, Pascal; Seepersaud, Mohindra

Agent Davies Collison Cave

Pub. Number AU-A-2008217187

PCT Pub. Number WO2008/101665

Priority 60/890,754 20.02.07 US

Filing date 19 February 2008

Wipo publication date 28 August 2008

International Classifications

C07D 257/02 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 285/00 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 515/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/101665 Priority application(s): WO2008/101665

30 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008217189-Method of purification of hydrophobic proteins

2008217180-Remote customisation module and system comprising said module